(Q45888118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sima Rafati

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Tahereh Taheri

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sahar Hosseinzadeh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Mehrdad Hashemi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

7

Yasaman Taslimi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

5

Farnaz Zahedifard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

9

Arash Memarnejadian

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Amin Daemi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

1 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

190-198

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Recombinant protein expression in Leishmania tarentolae

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Heat-shock proteins as powerful weapons in vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Enhanced immunogenicity of HPV16E7 accompanied by Gp96 as an adjuvant in two vaccination strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

A recombinant non-pathogenic Leishmania vaccine expressing human immunodeficiency virus 1 (HIV-1) Gag elicits cell-mediated immunity in mice and decreases HIV-1 replication in human tonsillar tissue following exposure to HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Immune modulation with high-dose heat-shock protein gp96: therapy of murine autoimmune diabetes and encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Development of HPV Vaccines for HPV-associated Head and Neck Squamous Cell Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

An overview of current delivery systems in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Differential presentation of tumor antigen-derived epitopes by MHC-class I and antigen-positive tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Immunization with adenoviral vectors carrying recombinant IL-12 and E7 enhanced the antitumor immunity to human papillomavirus 16-associated tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Trypanosoma cruzi as an effective cancer antigen delivery vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Recent advances in strategies for immunotherapy of human papillomavirus-induced lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

HER-2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell-mediated anti-tumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Regression of established human papillomavirus type 16 (HPV-16) immortalized tumors in vivo by vaccinia viruses expressing different forms of HPV-16 E7 correlates with enhanced CD8(+) T-cell responses that home to the tumor site

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Perspectives for preventive and therapeutic HPV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Immunomodulatory effects of IP-10 chemokine along with PEI600-Tat delivery system in DNA vaccination against HPV infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

GP96 C-terminal improves Her2/neu DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Evolution of heat shock protein and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Recombinant Leishmania tarentolae encoding the HPV type 16 E7 gene in tumor mice model.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Listeria-based HPV-16 E7 vaccines limit autochthonous tumor growth in a transgenic mouse model for HPV-16 transformed tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

Sustained low-level expression of interferon-gamma promotes tumor development: potential insights in tumor prevention and tumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10717544.2013.801534

10.3109/10717544.2013.801534

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23745741%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference